OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2020
(16)
2025
(4)
2022
(2)
2021
(1)
2017
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan.
Not available
S-EPMC8874464
|
biostudies-literature
Cite
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan.
Not available
S-EPMC9720426
|
biostudies-literature
Cite
Population-specific polygenic risk scores for people of Han Chinese ancestry.
Not available
S-EPMC12675292
|
biostudies-literature
Cite
Low-Density Lipoprotein Cholesterol and Mortality in Patients With Intracerebral Hemorrhage in Taiwan.
Not available
S-EPMC8802633
|
biostudies-literature
Cite
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Not available
S-EPMC12675286
|
biostudies-literature
Cite
Genetically Determined Plasma Lipid Levels and Risk of Diabetic Retinopathy: A Mendelian Randomization Study.
Not available
S-EPMC5697951
|
biostudies-literature
Cite
Comprehensive molecular characterization of mitochondrial genomes in human cancers.
Not available
S-EPMC7058535
|
biostudies-literature
Cite
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.
Not available
S-EPMC7002524
|
biostudies-literature
Cite
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
Not available
S-EPMC7002586
|
biostudies-literature
Cite
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Not available
S-EPMC7505971
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets